Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vidyalakshmi Chandramohan

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Oncoimmunology|February 6, 2014
A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastomaVidyalakshmi Chandramohan, Darell D Bigner
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Reciprocal control of Forkhead box O 3a and c-Myc via the phosphatidylinositol 3-kinase pathway coordinately regulates p27Kip1 levelsVidyalakshmi Chandramohan, Sébastien Jeay, Stefania Pianetti, et al.
Receptors & Clinical Investigation|March 14, 2017
EGFR/EGFRvIII-targeted immunotoxin therapy for the treatment of glioblastomas via convection-enhanced deliveryXuhui Bao, Ira Pastan, Darell D Bigner, et al.
Protein Engineering, Design & Selection : PEDS|October 6, 2017
Selection of novel affinity-matured human chondroitin sulfate proteoglycan 4 antibody fragments by yeast displayXin Yu, Liang Qu, Darell D Bigner, et al.
Clinical & Developmental Immunology|March 9, 2012
Toxin-based targeted therapy for malignant brain tumorsVidyalakshmi Chandramohan, John H Sampson, Ira Pastan, et al.
Journal of Immunological Methods|December 28, 2016
Development and validation of a cell-based fluorescent method for measuring antibody affinityXin Yu, Charles N Pegram, Darell D Bigner, et al.
Future Oncology (London, England)|July 11, 2013
Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumorsVidyalakshmi Chandramohan, Duane A Mitchell, Laura A Johnson, et al.
Plos One|March 20, 2024
Gene expression analysis suggests immunosuppressive roles of endolysosomes in glioblastomaMichael A Sun, Haipei Yao, Qing Yang, et al.
Plos One|January 10, 2019
Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumorsXin Yu, Mikhail Dobrikov, Stephen T Keir, et al.
Applied Microbiology and Biotechnology|December 26, 2016
Production and quality control assessment of a GLP-grade immunotoxin, D2C7-(scdsFv)-PE38KDEL, for a phase I/II clinical trialVidyalakshmi Chandramohan, Charles N Pegram, Hailan Piao, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Oncoimmunology|February 6, 2014
A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastomaVidyalakshmi Chandramohan, Darell D Bigner
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Reciprocal control of Forkhead box O 3a and c-Myc via the phosphatidylinositol 3-kinase pathway coordinately regulates p27Kip1 levelsVidyalakshmi Chandramohan, Sébastien Jeay, Stefania Pianetti, et al.
Receptors & Clinical Investigation|March 14, 2017
EGFR/EGFRvIII-targeted immunotoxin therapy for the treatment of glioblastomas via convection-enhanced deliveryXuhui Bao, Ira Pastan, Darell D Bigner, et al.
Protein Engineering, Design & Selection : PEDS|October 6, 2017
Selection of novel affinity-matured human chondroitin sulfate proteoglycan 4 antibody fragments by yeast displayXin Yu, Liang Qu, Darell D Bigner, et al.
Clinical & Developmental Immunology|March 9, 2012
Toxin-based targeted therapy for malignant brain tumorsVidyalakshmi Chandramohan, John H Sampson, Ira Pastan, et al.
Journal of Immunological Methods|December 28, 2016
Development and validation of a cell-based fluorescent method for measuring antibody affinityXin Yu, Charles N Pegram, Darell D Bigner, et al.
Future Oncology (London, England)|July 11, 2013
Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumorsVidyalakshmi Chandramohan, Duane A Mitchell, Laura A Johnson, et al.
Plos One|March 20, 2024
Gene expression analysis suggests immunosuppressive roles of endolysosomes in glioblastomaMichael A Sun, Haipei Yao, Qing Yang, et al.
Plos One|January 10, 2019
Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumorsXin Yu, Mikhail Dobrikov, Stephen T Keir, et al.
Applied Microbiology and Biotechnology|December 26, 2016
Production and quality control assessment of a GLP-grade immunotoxin, D2C7-(scdsFv)-PE38KDEL, for a phase I/II clinical trialVidyalakshmi Chandramohan, Charles N Pegram, Hailan Piao, et al.
Pageof 3